Molecular Chaperones and Co-chaperones as Therapeutic Targets for Cancer
Received Date: Jun 14, 2016 / Accepted Date: Jun 16, 2016 / Published Date: Jun 21, 2016
Cancer is a devastating disease that has affected millions of people, consumed tremendous efforts in the treatment/care and is incurable. Statistics from www.seer.cancer.gov show 14,140,254 people were living with cancer in 2013 in US with 1,685,210 new cases projected and 595,690 estimated deaths to occur due to cancer in 2016. Number of people surviving cancer (measured as 5-year survival rate) has increased by 18% (48.7% in 1975 to 66.9% in 2012) during the last half century. This number appears to be small if we consider the contribution of proactive care for example, early detections, and attention to life style and aggressive chemical/radiation therapy and at the same time stare at a bleak hope of any apparent breakthrough in next 10 years.
Keywords: radiation therapy; Carcinogen; Chaperons
Citation: Ahmad A, Muzaffar M (2016) Molecular Chaperones and Co-chaperones as Therapeutic Targets for Cancer. J Mol Pharm Org Process Res 4: e124. Doi: 10.4172/2329-9053.1000e124
Copyright: ©2016 Ahmad A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
- Total views: 9373
- [From(publication date): 6-2016 - May 27, 2018]
- Breakdown by view type
- HTML page views: 9226
- PDF downloads: 147